Buradasınız

Anasayfa » Content

KRONİK PERİTON DİYALİZİ TEDAVİSİ GÖREN ÇOCUKLARDA PLAZMA KARNİTİN DÜZEYLERİ

PLASMA CARNITINE LEVELS IN PEDIATRIC HEMODIALYSIS PATIENTS

Journal Name:

  • Türk Nefroloji, Diyaliz ve Transplantasyon Dergisi

Publication Year:

  • 2002

Key Words:

Keywords (Original Language):

Author NameUniversity of AuthorFaculty of Author
Abstract (2. Language): 
Plasma carnitine levels and the effect of oral L-carnitine supplementation on trigliceride and free faty acid levels were investigated in twenty uremic children on peritoneal dialysis. No difference was found between patients and controls groups in respect to plasma total carnitine levels. However free carnitine levels were found to be low while acyl carnitine levels were high than that controls. Consequently acyl carnitine/free carnitine balance was disturbed in patients. L-carnitine supplemantation at 50 mg/kg/day in patients, for one month, led to a significant increase ir total carnitine, free carnitine and acyl carnitine levels, •when compared with the previous levels but no significant change was observed in acyl carnitine/free carnitine balance. L-carnitine supplementation had also no effect on triglyceride and free faty acid levels.
Bookmark/Search this post with
Abstract (Original Language): 
Periton diyalizi tedavisi gören 20 çocukta plazma karnitin düzeyleri ve oral karnitin suplemantasyonunun trigliserid ve serbest yağ asidi düzeylerine etkisi araştırıldı. Hasta grubunun bazal total karnitin düzeyi kontrol grubundan farklı değildi, fakat hasta grubunda serbest karnitin düzeyleri düşük, acil karnitin düzeyleri yüksekti, dolayısıyla acil karnitin/serbest karnitin oranı bozulmuştu. Bir ay süreli oral 50 mg/kg/gün L-karnitin tedavisi ile hastaların plazma total karnitin, acil karnitin düzeyleri tedavi öncesi değerlere göre anlamlı ölçüde yükseldi. Fakat, acil karnitin/serbest karnitin oranı değişmedi. Keza, karnitin tedavisi ile, trigliserid, serbest yağ asidi, düzeylerinde anlamlı değişiklik gözlenmedi.
FULL TEXT (PDF): 
PDF icon pdf_tndt_371.pdf
  • 1
27-31
  • Turkish

REFERENCES

References: 

1. Borum PR. Carnitine. Ann Rev Nutr 1983;3:233-259.
2. Wanner C, Hörl WH. Carnitine abnormalities in patients with renal insufficiency. Nephron 1988;50:89-102.
3. Bohmer T, Bergrem H, Eiklid K. Carnitine deficiency induced during intermittent hemodialysis for renal failure. Lancet 1978;i:126-128.
4. Bertoli M, Battistella PA, Vergani L, et al. Carnitine deficiency induced during hemodialysis and hyperlipidemia: Effect of replacement therapy. Am J Clin Nutr 1981;34:1496-1500.
5. Gusmano R, Oleggini R, Perfumo F. Plasma carnitin concentrations and dyslipidemia in children on maintenance hemodialysis. J Pediatr 1981;99:429-432.
6. Bouncristiani U, Di Paolo N, Carobi C, et al. Progression of carnitine depletion in patients on long
term CAPD (Abstract) Perit Dial Bull 1984;4 (Suppl):
S.10.
7. Amair P, Gregoriadis A, Oreopoulas DG. Serum carnitine in patients on continuous ambulatory peritoneal dialysis. Perit Dial Bull 1982;2:11-12.
8. Moorthy AV, Shug AL. Elevated plasma carnitine levels
in patients on CAPD. Perit Dial Bull 1985;5:175-179.
9. Bizzi A, Cini M, Garattini S, et al. Carnitine addition to hemodialysis fluid prevents plasma carnitine deficiency
during dialysis. Lancet 1979;1:882-883.
10. Teodosiu DC, Kirby DP J, Short AH, et al. Free and
esterified carnitine in continuous ambulatory peritoneal
dialysis patients. Kidney Int 1996;49:158-162.
11. Poliakogiannis T, Chatzidimitriou C, Evangeliou A, et al. Serum carnitine levels, lipid profile, and metabolic status of patients on continuous ambulatory peritoneal dialysis. Perit Dial Int 1993;13 (Suppl 2):s440-s443.
12. Guarnieri G, Toigo G, Crapesi L, et al. Carnitine metabolism in chronic renal failure. Kidney Int 1987;32 (Suppl 22):sll6-sl27.
13. Moorthy AV, Rosenblum M, Rajaram R, et al. A comparison of plasma and muscle carnitine levels in patients on peritoneal or hemodialysis for chronic renal
failure. Am J Nephrol 1983;3:205-208.
14. Attman PO, Alaupovic P. Lipid abnormalities in chronic renal insufficiency. Kidney Int 1991;39:516-23.
15. Maebashi M, Kawamura N, Sato M, et al. Lipid-lowering effect of carnitine in patients with type IV hyperlipoproteinemia. Lancet 1978;2:805-807.
16. Bezzato G, Mezzina C, Ciman M, et al. Myaeshenia-like syndrome associated with carnitine in patients on long-
term hemodialysis. Lancet 1979;1:1041-1042.
17. Bougneres PF, Lacour B, Di Guiglo S, et al. Hypolipoemic effect of carnitin on uremic patients.
Lancet 1979;1:1401-1402.
18. Querfeld U, Salusky IB, Nelsonn P, et al.
Hyperlipidemia in pediatric patients undergoing
peritoneal dialysis. Ped Nephrol 1988;2:447-452.
19. Zilleruelo G, Freundlch M, Novak M, et al. Carnitine losses in children on hemodialysis and continuous ambulatory peritoneal dialysis. Pediatr Res 1984;18:373A.
20. Warady BA, Borum P, Stall C, et al. Carnitine status of pediatric patients on continuous ambulatory peritoneal
dialysis. Am J Nephrol 1990;10:109-114.
21. Murakami R, Momota- T, Yoshiya K, et al. Serum carnitine and nutritional status in children treated with continuous ambulatory peritoneal dialysis. J Pediatr
Gastroenterol Nutr 1990;l 1:371-374.
22. Cederblad G, Harper P, Lindgren K. Spectrophotometry of carnitine in biological fluids and tissue with a cobas
bio centrifugal analyzer. Clin Chem 1986;32:342-346.
23. Lipid Research Clinics Population Studies Data Book. Vol. 1, The prevalance study. Washington DC, National
Institutes of Health, NIH Publication 1980,No.80-1527.
24. Leschke M, Rumpf KW, Eisenhauer T, et al. Quantitative assesment of carnitine loss during hemodialysis and hemofiltration. Kidney Int 1983;24
(supll 16):sl43-s. 146.
30
25. Ahmad S, Brass EP, Hoppel C, et al. Role of L-carnitine in treating renal dilysis patients. Dial Transplant 1994;23:177-181.
26. Cham MK, Varghese Z, Moorhead JF. Lipid abnormalities in uremia, dialysis and transplantation. Kidney Int 1981;19:625-637.
27. Lacour B, Di Giulio S, Chanard J, et al. Carnitine imroves lipid anomalies in hemodialysis patients. Lancet 1980;ii:763-765.
28. Wanner C, Förstner-Wanner S, Shaeffer G, et al. Serum free carnitine, carnitine esters and lipids in patients on peritoneal dialysis and hemodialysis. Am J Nephrol 1986;6:206-211.

Thank you for copying data from http://www.arastirmax.com